Farcast Biosciences

Farcast Biosciences is a biotechnology startup that has been dedicated to building the most precise functional precision tumor microdynamics platform since its founding in 2010. Their slogan "24,000 human tumors and counting" reflects their commitment to accumulating a substantial dataset for comprehensive analysis. Farcast utilizes data from live human tumors to predict clinical response, with the ultimate goal of providing accurate insights into every patient tumor, every time. Their platform aims to contribute to improved outcomes for cancer patients in the Health Care and Pharmaceutical industries. Techstars' $120.00K Pre Seed Round investment in Farcast Biosciences in 15 July 2019 underscores the confidence of renowned investors in the potential of this India-based startup.